Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Just an example of a buyout.
View:
Post by askretka on May 09, 2021 6:31am

Just an example of a buyout.

. " NEW YORK (TheStreet) --Shares ofTobira Therapeutics(TBRA)are skyrocketing on heavy trading volume on Tuesday morning by over 700% to $39.24, after it was announced the clinical-stage biopharmaceutical company will be acquired byAllergan(AGN) in a deal valued at up to $1.7 billion." ---------------------------------- Jus putting this up as an example. ONC is still a spec buy but if a buyout happens you won't have time to react or buy shares. I'm in another promising small biotech with the same CEO as above buyout so just putting in as an example. Cheers!
Comment by westcoast1000 on May 10, 2021 12:40pm
Good post. Thanks, askretka.
Comment by fox7mf on May 10, 2021 2:03pm
Thx askretka, great post. I'm thinking Onc's buyout will come and it'll be 5 to 7 times the 1.7 billion Tobira received. My opinion.
Comment by JohnnyYeg on May 10, 2021 7:06pm
I think that multiplier for BC alone!
Oncolytics Biotech Inc